Related Experiment Video
Updated: Feb 2, 2026

Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs
Published on: June 23, 2022
Reactivation of dormant/latent fungal infection
Kevin Brunet1, Alexandre Alanio2, Olivier Lortholary3
1Laboratoire de Mycologie Médicale, CHU de Poitiers, Poitiers, France; INSERM U1070, Université de Poitiers, Poitiers, France.
Objectives:
Latent infections are well-known for bacteria such as Mycobacterium tuberculosis and for viruses such as Herpesviridae and parasites like Leishmania spp. or Toxoplasma gondii. However, invasive fungi may also be latent and come to reactivate. The aim of this review is to clarify the reactivation concept in major fungal invasive diseases.
Method:
We have searched for PUBMED publications from 1980 to 2017 with the keywords "fungi", "reactivation", "latency", "dormancy", "granuloma", "Aspergillus", "Mucorales", "Dimorphic fungi", "Histoplasma", "Cryptococcus", "Pneumocystis", "Yeast", "Candida" and "Mold".
Results:
After primary infection and immune control of the fungus, reactivation can occur following a period of latency. Two conditions must be present: dormancy/survival of the fungi and immunosuppression of the host. Fungal reactivation is easily demonstrated for dimorphic fungi when patients travelling in endemic areas are no longer exposed to fungi at the time they when develop the disease. For cosmopolitan fungi, such as Cryptococcus neoformans, Aspergillus or some emerging fungi, clinical data and animal models have brought some evidence of reactivation. Survival inside macrophages and granuloma formation appear to be predominant conditions to latency. Although granuloma may act as a reservoir for some fungi like Histoplasma or Cryptococcus, its role in mold reactivation has yet to be fully established.
Conclusions:
The risk of fungal reactivation should be taken into account in patient management, especially in cases of solid organ transplantation or long-term immunosuppressive treatment.
Insights
Fungal reactivation, following a latent period, occurs due to fungal dormancy and host immunosuppression. This risk is critical in immunocompromised patients, especially transplant recipients.
Area of Science:
- Mycology
- Infectious Diseases
- Immunology
Background:
- Latent infections are common for bacteria, viruses, and parasites.
- Invasive fungi can also establish latent infections and reactivate.
- Understanding fungal reactivation is crucial for managing invasive fungal diseases.
Purpose of the Study:
- To clarify the concept of reactivation in major invasive fungal diseases.
- To review the mechanisms and evidence of fungal latency and reactivation.
Main Methods:
- Literature search of PubMed (1980-2017).
- Keywords included "fungi", "reactivation", "latency", "dormancy", "granuloma", and specific fungal genera (e.g., Aspergillus, Cryptococcus).
Main Results:
- Fungal reactivation requires fungal dormancy and host immunosuppression.
- Evidence for reactivation exists for dimorphic fungi, Cryptococcus neoformans, Aspergillus, and emerging fungi.
- Survival within macrophages and granuloma formation are key to latency, though granuloma's role in mold reactivation needs further study.
Conclusions:
- Fungal reactivation poses a significant risk in immunocompromised individuals.
- Consideration of fungal reactivation is essential in managing patients undergoing transplantation or long-term immunosuppression.
Related Concept Videos
Fungal Group Zygomycota
Cross-reactivity
Reactivity of Enols
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota

